Trial of lesinurad in patients with gout and renal impairment.
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 09 Aug 2011
At a glance
- Drugs Lesinurad (Primary)
- Indications Gout
- Focus Pharmacodynamics
- 19 Jun 2010 Currently, four patients have completed dosing, according to an Ardea Biosciences media release.
- 19 Jun 2010 Status changed from planning to recruiting, based on an Ardea Biosciences media release.
- 22 Apr 2009 New trial record.